176 related articles for article (PubMed ID: 34837956)
1. DMAG, a novel countermeasure for the treatment of thrombocytopenia.
Lin J; Zeng J; Liu S; Shen X; Jiang N; Wu YS; Li H; Wang L; Wu JM
Mol Med; 2021 Nov; 27(1):149. PubMed ID: 34837956
[TBL] [Abstract][Full Text] [Related]
2. Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells.
Long W; Liu S; Li XX; Shen X; Zeng J; Luo JS; Li KR; Wu AG; Yu L; Qin DL; Hu GQ; Yang J; Wu JM
Pharmacol Res; 2021 Apr; 166():105491. PubMed ID: 33582247
[TBL] [Abstract][Full Text] [Related]
3. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J
Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424
[TBL] [Abstract][Full Text] [Related]
4. Two ellagic acids isolated from roots of Sanguisorba officinalis L. promote hematopoietic progenitor cell proliferation and megakaryocyte differentiation.
Gao X; Wu J; Zou W; Dai Y
Molecules; 2014 Apr; 19(4):5448-58. PubMed ID: 24879588
[TBL] [Abstract][Full Text] [Related]
5. Qihuang Zhuyu formula alleviates coronary microthrombosis by inhibiting PI3K/Akt/αIIbβ3-mediated platelet activation.
Ding Y; Xiang Q; Zhu P; Fan M; Tong H; Wang M; Cheng S; Yu P; Shi H; Zhang H; Chen X
Phytomedicine; 2024 Mar; 125():155276. PubMed ID: 38295661
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
[TBL] [Abstract][Full Text] [Related]
7. A Novel Antithrombocytopenia Agent,
Chen W; Zhu L; Wang L; Zeng J; Wen M; Xu X; Zou L; Huang F; Huang Q; Qin D; Mei Q; Yang J; Wang Q; Wu J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430539
[TBL] [Abstract][Full Text] [Related]
8. Alnustone promotes megakaryocyte differentiation and platelet production via the interleukin-17A/interleukin-17A receptor/Src/RAC1/MEK/ERK signaling pathway.
Li Y; Lai J; Ran M; Yi T; Zhou L; Luo J; Liu X; Tang X; Huang M; Xie X; Li H; Yang Y; Zou W; Wu J
Eur J Pharmacol; 2024 May; 971():176548. PubMed ID: 38570080
[TBL] [Abstract][Full Text] [Related]
9. Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
Zhou L; Ni C; Liao R; Tang X; Yi T; Ran M; Huang M; Liao R; Zhou X; Qin D; Wang L; Huang F; Xie X; Wan Y; Luo J; Wang Y; Wu J
Elife; 2024 Apr; 13():. PubMed ID: 38573820
[TBL] [Abstract][Full Text] [Related]
10. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
[TBL] [Abstract][Full Text] [Related]
11. Xanthotoxin, a novel inducer of platelet formation, promotes thrombocytopoiesis via IL-1R1 and MEK/ERK signaling.
Lai J; Li Y; Ran M; Huang Q; Huang F; Zhu L; Wu Y; Zou W; Xie X; Tang Y; Yang F; Wu A; Ge G; Wu J
Biomed Pharmacother; 2023 Jul; 163():114811. PubMed ID: 37156117
[TBL] [Abstract][Full Text] [Related]
12. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway.
Ye JY; Chan GC; Qiao L; Lian Q; Meng FY; Luo XQ; Khachigian LM; Ma M; Deng R; Chen JL; Chong BH; Yang M
Haematologica; 2010 Oct; 95(10):1745-53. PubMed ID: 20562316
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of astragaloside Ⅳ alleviating PC12 cell injury by activating PI3K/AKT signaling pathway: based on network pharmacology and in vitro experiments].
Zhang TQ; Li CC; Zhang TF; Wang MY; Cui SN; Huo Q
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6465-6473. PubMed ID: 34994139
[TBL] [Abstract][Full Text] [Related]
15. Increased prostacyclin levels inhibit the aggregation and activation of platelets via the PI3K-AKT pathway in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Zhang XH; Zhou SY; Feng R; Wang YZ; Kong Y; Zhou Y; Zhang JM; Wang M; Zhao JZ; Wang QM; Feng FE; Zhu XL; Wang FR; Wang JZ; Han W; Chen H; Xu LP; Liu YR; Liu KY; Huang XJ
Thromb Res; 2016 Mar; 139():1-9. PubMed ID: 26916289
[TBL] [Abstract][Full Text] [Related]
16. Ferric Ion Induction of Triggering Receptor Expressed in Myeloid Cells-2 Expression and PI3K/Akt Signaling Pathway in Preosteoclast Cells to Promote Osteoclast Differentiation.
Liu LL; Cao ZH; He CL; Zhong YC; Liu WY; Zhang P; Yang F; Xu YJ
Orthop Surg; 2020 Aug; 12(4):1304-1312. PubMed ID: 32729185
[TBL] [Abstract][Full Text] [Related]
17. Hirsutine, a novel megakaryopoiesis inducer, promotes thrombopoiesis via MEK/ERK/FOG1/TAL1 signaling.
Kang Y; Lin J; Wang L; Shen X; Li J; Wu A; Yue L; Wei L; Ye Y; Yang J; Wu J
Phytomedicine; 2022 Jul; 102():154150. PubMed ID: 35569185
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
Liu H; Li X; Duan Y; Xie JB; Piao XL
J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into the renoprotective role of curcumin in cisplatin-induced acute kidney injury: network pharmacology analysis and experimental validation.
Hui Z; Dong QQ; Shu HP; Tu YC; Liao QQ; Yao LJ
Bioengineered; 2021 Dec; 12(2):11041-11056. PubMed ID: 34802380
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological mechanism and therapeutic efficacy of Icariside II in the treatment of acute ischemic stroke: a systematic review and network pharmacological analysis.
Wang X; Li J; Liu L; Kan JM; Niu P; Yu ZQ; Ma C; Dong F; Han MX; Li J; Zhao DX
BMC Complement Med Ther; 2022 Sep; 22(1):253. PubMed ID: 36180911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
